Conclusions Combination detection of EMA, EGP 2 and CK19 improves the diagnostic sensitivity and accuracy, and may play an important role in the prognosis and treatment of breast cancer.
结论联合检测ema、EGP 2和CK 19可提高诊断正确率,有可能在乳腺癌预后预测和治疗中发挥作用。
Objective to investigate the expression of EMA and EGP-2 in breast carcinoma tissues, to analyze their relationship with clinical indexes and to observe the correlation with their expression.
目的通过检测上皮膜抗原(EMA)、表皮糖蛋白基因(EGP - 2)在乳腺癌组织中的表达,分析它们与乳腺癌临床病理指标的关系,并研究两者表达的相关性。
This antigen is also known as epithelial surface antigen (ESA) and epithelial glycoprotein 2 (EGP-2).
这种抗原也被称为上皮表面抗原(esa)和上皮糖蛋白- 2 (EGP - 2)。
应用推荐